Daily TIP

The Daily TIP: J. K. Rowling Assails Fellow Author for Charging Jewish Outrage at Labour is “Synthetic”

Posted by Tip Staff - August 28, 2018

J. K. Rowling Assails Fellow Author for Charging Jewish Outrage at Labour is “Synthetic”
Iran Allows Dual Citizen Furlough to See Daughter; Sends Her Back to Prison After 3 Days
Iran Hunting Down Kurdish Fighters who Helped Defeat ISIS
Israeli Researchers Discover Possible Breakthrough in Cure for Acute Leukemia

J. K. Rowling Assails Fellow Author for Charging Jewish Outrage at Labour is “Synthetic”

British novelist J. K. Rowling stepped up her defense of Jews against anti-Semitism on Sunday in a heated Twitter exchange with Simon Maginn, an author and supporter of Labour leader Jeremy Corby, The Algemeiner reported.

In a tweet, Maginn had called Jewish outrage over Corbyn’s 2013 comments indicating that “Zionists” do not understand British culture “patently synthetic outrage,” and demanded that a Jewish tweeter explain his “deep and wounding sense of injury.”

Rowling, who created the Harry Potter series and is not herself Jewish, slammed Maginn for his comments and replied: “How dare you tell a Jew that their outrage is ‘patently synthetic’? How dare you demand that they lay bare their pain and fear on demand, for your personal evaluation?”

Rowling continued: “What other minority would you speak to this way?”

In the cause of the exchange, the bestselling novelist quoted extensively from the classic 1946 essay by the French leftist philosopher, Jean-Paul Sartre, titled, “Antisemite and Jew.”

“They (antisemites) delight in acting in bad faith, since they seek not to persuade by sound argument but to intimidate and disconcert,” Rowling tweeted to her 14.4 million followers on Twitter.

Maginn accused Rowling of “libel” over accusations of anti-Semitism but said he would not take legal action against the novelist. “I’m not going to mount a legal action against you because I haven’t got any money and you’ve got a lot, but false + defamatory = libellous. What a class act you are. What a nasty vicious little bully. Blocked.”

Iran Allows Dual Citizen Furlough to See Daughter; Sends Her Back to Prison After 3 Days

After allowing a dual British-Iranian citizen a furlough from jail to reunite with her four-year-old daughter, the Iranian regime ordered her back to jail after three days, CNN reported Sunday.

Nazanin Zaghari-Ratcliffe, a project manager at the Thomson Reuters Foundation, was separated from her toddler daughter Gabriella, and arrested in April 2016, while preparing to depart from Tehran’s international airport. She had been in Iran visiting her family.

Ratcliffe voluntarily returned to jail on Sunday so that her daughter would not have to see her "dragged out of bed in the middle of the night," according to a statement released by Richard Ratcliffe, her husband.

Reuters reported last November that Iran has arrested at least 30 dual-nationals since the nuclear deal was agreed to in 2015, including Ratcliffe.

She had been sentenced to five years in jail for allegedly working to overthrow the Iranian regime, and Gabriella given to the care of Ratcliffe's parents while her mother is imprisoned. The regime has said that Ratcliffe will face a new trial for further security-related offenses.

Iran had told Zaghari-Ratcliffe’s family in July 2016 to “make an arrangement” to get her released before trial, for some sort of “exchange.” Ratcliffe’s ordeal helped prompt the United Kingdom’s Foreign and Commonwealth Office to upgrade its warning to citizens not to visit Iran out of concern that they could be “arbitrarily detained.”

Iran Hunting Down Kurdish Fighters who Helped Defeat ISIS

The Iranian regime is hunting Iranian Kurds from Iran, who fled the Islamic Republic’s repression to find refuge in the autonomous Kurdistan Regional Government in Iraq and helped defeat ISIS, Seth J. Frantzman reported in The Jerusalem Post on Tuesday.

The Kurdistan Freedom Party (PAK) consists of a small group of skilled fighters, who together with the Peshmerga, the official army of the Kurdistan region, defended the territory against ISIS at several frontlines held by Kurdish forces between 2014 and 2017.

According to PAK, four of their members have recently been killed by the Iranian regime. A man called “Malek” was poisoned. Another fighter, Arman Ghafouri, was tortured and killed. The other two PAK members were kidnapped by the regime, accused of supporting the popular uprising that have swept across Iran over the last months.

PAK said “Malek” was in western Iran to visit his family, when he was kidnapped by Iranian authorities. “He was caught on March 3, and was taken by the Ettela’at [intelligence services]. After many sessions of questions and a series of torture, he did not share any information and was not ready to work with the regime.” The group said he was then poisoned.

“On August 9, two other PAK members were on their way to rescue a wounded Peshmerga from PAK near Saqqez.” According to the statement, they were taken by the Islamic Revolutionary Guard Corps (IRGC) – an entity designated by the United States government as a terrorist organization.

Israeli Researchers Discover Possible Breakthrough in Cure for Acute Leukemia

Prof. Yinon Ben-Neriah and his research team at the Hebrew University of Jerusalem’s Faculty of Medicine have developed a new biological drug showing a cure rate of 50 percent for lab mice with acute myeloid leukemia — one of the most aggressive cancers.

Published last week in the scientific journal Cell, the study is especially significant because treatments for leukemia haven’t progressed much in the past 40 years.

Acute leukemia is defined by the US National Cancer Institute as “a rapidly progressing cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of white blood cells to be produced and enter the bloodstream.” Leukemia may affect red blood cells, white blood cells or platelets.

In the abnormal leukemic blood cells, a large number of varied proteins are produced. They work together to provide the cancerous cells with the ability to grow rapidly and to overcome the assault of chemotherapy.

The new drug developed by Ben-Neriah and his team functions like a cluster bomb. It attacks several leukemic proteins at once, making it difficult for the leukemia cells to activate other proteins that can evade the therapy.

Furthermore, this single-molecule drug accomplishes the work of three or four separate drugs. If it were to be used in humans, one of its potential advantages would be to reduce the number of different drugs – each with its own side effects — to which cancer patients would need to be exposed.

(via Israel21c)

Be the first to comment

Please check your e-mail for a link to activate your account.